Biotech Neurocrine Biosciences Launches Interactive Educational Resources to Support Clinical Learning in Classic Congenital Adrenal Hyperplasia October 31, 2026
Biotech Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. October 30, 2026
Biotech INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP) October 30, 2026
Biotech Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution October 30, 2026
Biotech Rigel Announces Conference Call and Webcast to Report Third Quarter 2026 Financial Results October 30, 2026
Biotech Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors October 30, 2026
Biotech BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease October 30, 2026